advertisement
Shi Y 19
Showing records 1 to 19 | Display all abstracts from Shi Y100461 Weill-Marchesani syndrome 4 caused by compound heterozygosity of a maternal submicroscopic deletion and a paternal nonsense variant in the gene: A case report
Yu X
American journal of ophthalmology case reports 2022; 26: 101541
100826 Relationship Between SGLT-2i and Ocular Diseases in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
Zhou B
Frontiers in endocrinology 2022; 13: 907340
99986 Intravitreal Injection of PACAP Attenuates Acute Ocular Hypertension-Induced Retinal Injury Via Anti-Apoptosis and Anti-Inflammation in Mice
Lu P; Shi Y
Investigative Ophthalmology and Visual Science 2022; 63: 18
100461 Weill-Marchesani syndrome 4 caused by compound heterozygosity of a maternal submicroscopic deletion and a paternal nonsense variant in the gene: A case report
Kline B
American journal of ophthalmology case reports 2022; 26: 101541
100826 Relationship Between SGLT-2i and Ocular Diseases in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
Shi Y; Fu R
Frontiers in endocrinology 2022; 13: 907340
100461 Weill-Marchesani syndrome 4 caused by compound heterozygosity of a maternal submicroscopic deletion and a paternal nonsense variant in the gene: A case report
Han Y
American journal of ophthalmology case reports 2022; 26: 101541
100826 Relationship Between SGLT-2i and Ocular Diseases in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
Fu R
Frontiers in endocrinology 2022; 13: 907340
99986 Intravitreal Injection of PACAP Attenuates Acute Ocular Hypertension-Induced Retinal Injury Via Anti-Apoptosis and Anti-Inflammation in Mice
Ye D
Investigative Ophthalmology and Visual Science 2022; 63: 18
100461 Weill-Marchesani syndrome 4 caused by compound heterozygosity of a maternal submicroscopic deletion and a paternal nonsense variant in the gene: A case report
Gao Y
American journal of ophthalmology case reports 2022; 26: 101541
99986 Intravitreal Injection of PACAP Attenuates Acute Ocular Hypertension-Induced Retinal Injury Via Anti-Apoptosis and Anti-Inflammation in Mice
Lu X
Investigative Ophthalmology and Visual Science 2022; 63: 18
100826 Relationship Between SGLT-2i and Ocular Diseases in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
Ni H; Gu L
Frontiers in endocrinology 2022; 13: 907340
99986 Intravitreal Injection of PACAP Attenuates Acute Ocular Hypertension-Induced Retinal Injury Via Anti-Apoptosis and Anti-Inflammation in Mice
Tang X
Investigative Ophthalmology and Visual Science 2022; 63: 18
100461 Weill-Marchesani syndrome 4 caused by compound heterozygosity of a maternal submicroscopic deletion and a paternal nonsense variant in the gene: A case report
Fan Z
American journal of ophthalmology case reports 2022; 26: 101541
99986 Intravitreal Injection of PACAP Attenuates Acute Ocular Hypertension-Induced Retinal Injury Via Anti-Apoptosis and Anti-Inflammation in Mice
Cheng L
Investigative Ophthalmology and Visual Science 2022; 63: 18
100826 Relationship Between SGLT-2i and Ocular Diseases in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
Si Y
Frontiers in endocrinology 2022; 13: 907340
100461 Weill-Marchesani syndrome 4 caused by compound heterozygosity of a maternal submicroscopic deletion and a paternal nonsense variant in the gene: A case report
Shi Y
American journal of ophthalmology case reports 2022; 26: 101541
100826 Relationship Between SGLT-2i and Ocular Diseases in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
Zhang M
Frontiers in endocrinology 2022; 13: 907340
99986 Intravitreal Injection of PACAP Attenuates Acute Ocular Hypertension-Induced Retinal Injury Via Anti-Apoptosis and Anti-Inflammation in Mice
Xu Y; Huang J
Investigative Ophthalmology and Visual Science 2022; 63: 18
100826 Relationship Between SGLT-2i and Ocular Diseases in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
Jiang K; Shen J; Li X; Sun X
Frontiers in endocrinology 2022; 13: 907340
